IP Library Granted Patent US 10,809,167
Granted Patent B2
US 10,809,167 · App. 13/819,574 · Granted Oct 20, 2020

Tissue staining method with staining agent containing particle holding plural phosphors

Inventors: Takuji Aimiya (Nishitokyo, JP); Hideki Gouda (Tokyo, JP); Hisatake Okada (Tachikawa, JP); Yasushi Nakano (Hino, JP); Kohsuke Gonda (Miyagi, JP); Motohiro Takeda (Miyagi, JP); Noriaki Ohuchi (Miyagi, JP)
Assignee: KONICA MINOLTA, INC.
G01N1/30B82Y15/00B82Y30/00G01N21/6428G01N33/582G01N33/588G01N33/74G01N33/743G01N2001/302G01N2021/6441G01N2333/71G01N2333/723G01N2333/91205
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,809,167
App. No.
13/819,574
Granted
Oct 20, 2020
Kind
B2
Abstract

A tissue staining method which comprises: staining a tissue with a staining reagent wherein a biosubstance recognition site is bonded to particles carrying multiple fluorescent substances accumulated therein; in the stained tissue, counting fluorescent points or measuring fluorescent brightness; and evaluating the expression level of a biosubstance, which matches the biosubstance recognition site, in the aforesaid tissue on the basis of the number of the fluorescent points or fluorescent brightness that was measured.

Claims (19)

1. A tissue staining method, comprising:

staining a tissue with a staining reagent which comprises particles each of which comprises (i) an organic fluorescent dye contained in the particle and (ii) a target-substance-recognizing body bonded to the particle,

wherein the target-substance-recognizing body binds to a target substance present in the stained tissue to enable counting of the number of the target substance as bright spots of fluorescence in the tissue so as to evaluate the existence of the target substance on the basis of the number of the bright spots,

wherein an average particle diameter of the particles each of which comprises the organic fluorescent dye contained in the particle and the target-substance recognizing body bonded to the particle is in a range of 40 to 500 nm, and a variation coefficient of particle diameter of the particles each of which further comprises the organic fluorescent dye and the target-substance recognizing body is in a range of 5 to 15%.

2. The tissue staining method according to claim 1 , wherein

the organic fluorescent dye is inside each of the particles.

3. The tissue staining method according to claim 1 , further comprising counting the number of the bright spots in the stained tissue.

4. The tissue staining method according to claim 3 , further comprising evaluating the existence of the target substance in the stained tissue on the basis of the number of the bright spots.

5. The tissue staining method according to claim 1 , further comprising:

determining a brightness per particle based on a brightness distribution of the bright spots in the stained tissue; and

determining a total number of the particles each including the organic fluorescent dye per cell in the stained tissue by dividing a total brightness per cell by the brightness per particle.

6. The tissue staining method according to claim 1 , wherein the target substance is a protein and the target-substance-recognizing body binds to the protein.

7. The tissue staining method according to claim 6 , wherein the target-substance-recognizing body comprises an anti-HER2 antibody or an anti-ER antibody.

8. The tissue staining method according to claim 6 , wherein the particles are silica nanoparticles or polylactic acid nanoparticles.

9. The tissue staining method according to claim 1 , wherein the particles are silica nanoparticles or polylactic acid nanoparticles.

10. The tissue staining method according to claim 1 , wherein the organic fluorescent dye comprises at least one dye selected from a group consisting of fluorescein dye molecules, rhodamine dye molecules, green dye molecules, cascade dye molecules, coumarin dye molecules, eosin dye molecules, NBD dye molecules, pyrene dye molecules, red dye molecules, and cyanine dye molecules.

11. The tissue staining method according to claim 1 , wherein the organic fluorescent dye has an excitation wavelength of 550-650 nm and an emission wavelength of 570-670 nm.

12. The tissue staining method according to claim 1 , wherein the dye is chemically bonded to the particles inside the particles.

13. The tissue staining method according to claim 1 , wherein the average particle diameter is 40 to 204 nm.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Sep 15, 2020
From: KONICA MINOLTA MEDICAL & GRAPHIC, INC.; KONICA MINOLTA HOLDINGS, INC.
To: KONICA MINOLTA, INC.
Reel/Frame 053772/0258 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2016
From: TOHOKU UNIVERSITY
To: KONICA MINOLTA, INC.
Reel/Frame 037607/0801 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2013
From: AIMIYA, TAKUJI; GOUDA, HIDEKI; OKADA, HISATAKE; NAKANO, YASUSHI; GONDA, KOHSUKE; TAKEDA, MOTOHIRO; OHUCHI, NORIAKI
To: KONICA MINOLTA MEDICAL & GRAPHIC, INC.; TOHOKU UNIVERSITY
Reel/Frame 029888/0273 →
Priority Claims (3)
JP 2010-191621 · Aug 30, 2010 · national
JP 2010-193153 · Aug 31, 2010 · national
JP 2010-193155 · Aug 31, 2010 · national
Continuity (1)
Related Publication 20130157895A1 · Jun 20, 2013